SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-050069
Filing Date
2022-08-22
Accepted
2022-08-22 16:30:26
Documents
13
Period of Report
2022-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164203-8k_somalogic.htm   iXBRL 8-K 40036
  Complete submission text file 0001213900-22-050069.txt   257870

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE slgc-20220816.xsd EX-101.SCH 3806
3 XBRL DEFINITION FILE slgc-20220816_def.xml EX-101.DEF 26767
4 XBRL LABEL FILE slgc-20220816_lab.xml EX-101.LAB 37000
5 XBRL PRESENTATION FILE slgc-20220816_pre.xml EX-101.PRE 25391
7 EXTRACTED XBRL INSTANCE DOCUMENT ea164203-8k_somalogic_htm.xml XML 5762
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 221184072
SIC: 8731 Services-Commercial Physical & Biological Research